Bayerische Motoren Werke ADR (BMWYY)
29.20
+0.00 (0.00%)
OP · Last Trade: Oct 22nd, 4:04 PM EDT
Detailed Quote
| Previous Close | 29.20 |
|---|---|
| Open | - |
| Bid | - |
| Ask | - |
| Day's Range | N/A - N/A |
| 52 Week Range | N/A - N/A |
| Volume | 0 |
| Market Cap | - |
| PE Ratio (TTM) | - |
| EPS (TTM) | - |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | - |
Chart
News & Press Releases
Amsterdam, The Netherlands – October 22, 2025 – A deepening geopolitical standoff over Nexperia, a critical Dutch-headquartered semiconductor manufacturer, is sending shockwaves through the global automotive industry, threatening imminent production halts across Europe and beyond. The dispute, stemming from the Dutch government's unprecedented intervention into the Chinese-owned chipmaker and Beijing's swift retaliation, has laid bare [...]
Via TokenRing AI · October 22, 2025
Volkswagen (XTRA: VOW) has once again sounded the alarm over potential production interruptions, citing renewed semiconductor supply chain challenges exacerbated by escalating geopolitical tensions. The German automotive giant's warning, issued in mid-to-late October 2025, underscores the enduring fragility of global manufacturing networks and the critical role semiconductors play in modern vehicles. This latest development, rooted [...]
Via TokenRing AI · October 22, 2025
Izotropic Corp. (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) Highlights Breast Cancer Awareness Month by Addressing Gaps in Screening and Advancing the IzoView Breast CT Solution
Izotropic (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3), a medical device firm leading imaging-based solutions for better diagnosis, screening, and treatment of breast cancer patients, is bringing the challenges of current screening systems and the unique potential of the IzoView Breast CT Imaging solutions as part of efforts to mark Breast Cancer Awareness Month ( ibn.fm/Hml57 ).
Via Investor Brand Network · October 22, 2025
The Street spotlights five emerging micro-cap innovators reshaping their respective industries—from blockchain finance and AI cybersecurity to advanced mineral exploration, digital advertising, and regenerative biotechnology. As market interest accelerates toward companies driving innovation with measurable traction, these five companies below are capturing attention through strategic developments, leadership milestones, and breakthrough technologies that position them at the forefront of their respective sectors.
Via AB Newswire · October 21, 2025
Specificity, Inc. (OTCQB: SPTY), a leading digital marketing and ad tech innovator, announced the appointment of Robert Fedder as Chief Executive Officer. Fedder brings over 30 years of international leadership across Europe, the U.S., Australia, and Asia, with a proven record in scaling technology ventures and driving operational excellence.
Via AB Newswire · October 21, 2025
Amsterdam, Netherlands – October 21, 2025 – A deepening geopolitical rift between the Netherlands and China over the critical chipmaker Nexperia has sent shockwaves through the global automotive supply chain and intensified international trade tensions. The Dutch government's unprecedented move to seize control of Nexperia, citing national economic security and severe governance shortcomings, has triggered [...]
Via TokenRing AI · October 21, 2025
Researchers Develop Nanoparticles That Could Combat Scarring, Inflammation in ARLD
In the U.S., liver disease claims the lives of at least 52,000 people annually. Globally, statistics suggest that 1.5 billion individuals are affected by liver disease. However, ARLD, or alcohol-related liver disease, hasn’t garnered traction within the scientific community, until now .
Via Investor Brand Network · October 21, 2025
Nanomedicine’s Next Leap: Why Particle Size Matters in Cancer Drug Delivery
Oncotelic Therapeutics Inc. (OTCQB: OTLC) is advancing precision nanomedicine with its proprietary Deciparticle(TM) platform, beginning human trials for Sapu003, a 20nm nanoparticle formulation of Everolimus (Afinitor(R)). This scientific briefing explores why particle size is critical to drug efficacy, how Oncotelic’s technology enhances tumor targeting, and how its rapid IND platform accelerates clinical development across multiple assets.
Via Investor Brand Network · October 21, 2025
Dubai, United Arab Emirates--(Newsfile Corp. - October 21, 2025) - OneClickDrive has released new insights from its marketplace data, revealing...
Via Newsfile · October 21, 2025
Bimmer Performance Center has officially moved into its new state-of-the-art facility at 5014 Departure Drive, Raleigh, bringing a higher level of care, comfort, and performance to BMW service in the Triangle.
Via AB Newswire · October 20, 2025
PLANT CITY, FL - October 20, 2025 - My Car Guy of Plant City, located at 1410 E Baker St, is celebrating two years of providing expert European auto repair and full-service care to the Plant City community. Known as the area’s only European vehicle specialist, the shop is now preparing to launch a new customer-focused website designed to further enhance the service experience.
Via Get News · October 20, 2025
Washington D.C., October 19, 2025 – The global financial markets are still reeling from the seismic shift in trade policy enacted by the United States in April 2025. A comprehensive package of new trade tariffs, spearheaded by the administration, has fundamentally challenged decades of global economic integration, ushering in an
Via MarketMinute · October 19, 2025
These businesses are poised to grow over the long term.
Via The Motley Fool · October 19, 2025
The global semiconductor landscape is once again a battleground, with renewed geopolitical tensions threatening to reshape supply chains and challenge technological independence, particularly across Europe. As the world races towards an AI-driven future, access to cutting-edge chips has become a strategic imperative, fueling an intense rivalry between major economic powers. This escalating competition, marked by [...]
Via TokenRing AI · October 17, 2025
Virtual Brain Tumors Could Transform How Cancer is Treated
Brain tumors, such as glioblastoma, are very hard to treat and even surgery isn’t sufficient to fully remove the tumor since tiny particles of cancerous cells remain and proliferate within a short time. However, ongoing work at Cedars-Sinai promises to transform brain cancer treatment by creating a digital twin of a patient’s tumor and then predicting how the cancer will grow and how it could respond to different therapies. In this way, treatment teams can better personalize treatments for individual patients.
Via Investor Brand Network · October 17, 2025
Orlando Executive Transportation (OET) has been recognized as the Best Luxury Chauffeur Service in Central Florida for 2025 by the prestigious Evergreen Awards, highlighting the company’s commitment to luxury, customer satisfaction, and service excellence.
Via Press Release Distribution Service · October 16, 2025
GM, Ford Stocks Slip As China-Dutch Chip Dispute Over Nexperia Sparks Fresh Supply Chain Fearsstocktwits.com
Via Stocktwits · October 16, 2025
Luxury Travel: Experience London with a Personal Car and Driver
London, a city steeped in history, culture, and modern sophistication, attracts millions of visitors each year. Whether you’re arriving for business, leisure, or a special occasion, how you move around the city can shape your overall experience. Public transport might be efficient, but for those who value comfort, privacy, and convenience, hiring a private car with a driver offers an unmatched level of luxury and ease. This option is increasingly becoming popular among travelers who want to enjoy the city’s charm without the hassle of navigating traffic, parking, or routes.
Via AB Newswire · October 16, 2025
Researchers Urge Canadians to Donate Toenails, for Science
A new study that is being planned by scientists at the University of Calgary, Canada, is looking to receive up to 10,000 toenail samples from volunteers around the country. The reason for this seemingly odd request is to study how to accurately measure how much radon someone has been exposed to and link this exposure to their risk of developing lung cancer .
Via Investor Brand Network · October 16, 2025
BioMedNewsBreaks — Adageis CEO Discusses AI-Driven Solutions for Value-Based Care in Latest Bell2Bell Podcast
Adageis, a healthcare technology company revolutionizing patient care through innovative digital solutions, is featured in the latest episode of The Bell2Bell Podcast, produced by IBN, a multifaceted communications organization connecting public companies with the investment community. In the interview, Adageis CEO Shane Speirs explains how the company’s AI-powered platform simplifies the administrative challenges of delivering value-based care by digitizing complex insurance and compliance processes. “We make it easy to see what measures practices need to hit and how to hit them for each individual patient,” Speirs said, noting that Adageis currently supports more than 580,000 patient lives. The conversation explores Adageis’ scalable per-provider model, rapid growth, and mission to make value-based care accessible to all providers.
Via Investor Brand Network · October 15, 2025
On October 14, 2025, Tesla (NASDAQ: TSLA) is not just making headlines in the automotive world, but also as a formidable force and a top stock mover in the energy sector. The company's relentless innovation and strategic expansion in energy storage and charging infrastructure are reshaping the global transition to
Via MarketMinute · October 14, 2025
The American automotive market witnessed an unprecedented milestone in September 2025, as the average price of a new vehicle in the U.S. surged to a record-high of $50,080. This marks the first time new car prices have crossed the $50,000 threshold, a significant leap driven primarily by
Via MarketMinute · October 14, 2025
A groundbreaking wave of Artificial Intelligence (AI) tools is poised to fundamentally transform materials quality checking, ushering in an era of unparalleled precision, speed, and cost-efficiency across critical industries. This new AI tool has made checking the quality of materials significantly easier, with profound and immediate implications for sectors such
Via MarketMinute · October 14, 2025
BioMedNewsBreaks — TransCode Therapeutics, Inc. (NASDAQ: RNAZ) Completes Phase 1a Trial of TTX-MC138, Advancing to Phase 2 Evaluation
TransCode Therapeutics (NASDAQ: RNAZ) announced completion of its Phase 1a clinical trial of TTX-MC138, an investigational inhibitor of microRNA-10b, achieving its primary safety endpoint and establishing a recommended Phase 2 dose. Sixteen patients were treated with no significant safety events or dose-limiting toxicities observed, and 44% achieved stable disease lasting four months or longer. The favorable safety, durability, and pharmacodynamic data support advancing TTX-MC138 into a Phase 2a trial to further assess efficacy across multiple metastatic cancer indications.
Via Investor Brand Network · October 14, 2025
BioMedNewsBreaks – NextPlat Corp (NASDAQ: NXPL, NXPLW) Appoints Amanda L. Ferrio as Chief Financial Officer
NextPlat (NASDAQ: NXPL, NXPLW), a global consumer products and services company providing healthcare and technology solutions through e-commerce and retail channels, announced the promotion of Amanda L. Ferrio to Chief Financial Officer, succeeding Cecile Munnik, CPA/CA, following a transition period through the company’s Q3 2025 filing. Ferrio, who has over 15 years of accounting and finance experience, previously served as Vice President of Accounting & Finance at Progressive Care LLC, where she led financial reporting, budgeting, and SEC compliance. CEO David Phipps said her deep operational insight will support NextPlat’s focus on financial performance and sustainable shareholder value.
Via Investor Brand Network · October 14, 2025